PUBLICATIONS
The utility of next-generation sequencing technologies in diagnosis of Mendelian mitochondrial diseases and reflections on clinical spectrum
Objectives
Diagnostic process of mitochondrial disorders (MD) is challenging because of the clinical variability and genetic heterogeneity of these conditions. Next-Generation Sequencing (NGS) technology offers a high-throughput platform for nuclear MD.
Methods
We included 59 of 72 patients that undergone WES and targeted exome sequencing panel suspected to have potential PMDs. Patients who were included in the analysis considering the possible PMD were reviewed retrospectively and scored according to the Mitochondrial Disease Criteria Scale.
Results
Sixty-one percent of the patients were diagnosed with whole-exome sequencing (WES) (36/59) and 15% with targeted exome sequencing (TES) (9/59). Patients with MD-related gene defects were included in the mito group, patients without MD-related gene defects were included in the nonmito group, and patients in whom no etiological cause could be identified were included in the unknown etiology group. In 11 out of 36 patients diagnosed with WES, a TES panel was applied prior to WES. In 47 probands in 39 genes (SURF1, SDHAF1, MTO1, FBXL4, SLC25A12, GLRX5, C19oRF12, NDUFAF6, DARS2, BOLA3, SLC19A3, SCO1, HIBCH, PDHA1, PDHAX, PC, ETFA, TRMU, TUFM, NDUFS6, WWOX, UBCD TREX1, ATL1, VAC14, GFAP, PLA2G6, TPRKB, ATP8A2, PEX13, IGHMBP2, LAMB2, LPIN1, GFPT1, CLN5, DOLK) (20 mito group, 19 nonmito group) 59 variants (31 mito group, 18 nonmito group) were detected. Seven novel variants in the mito group (SLC25A12, GLRX5, DARS2, SCO1, PC, ETFA, NDUFS6), nine novel variants in the nonmito group (IVD, GCDH, COG4, VAC14, GFAP, PLA2G6, ATP8A2, PEX13, LPIN1) were detected.
Conclusions
We explored the feasibility of identifying pathogenic alleles using WES and TES in MD. Our results show that WES is the primary method of choice in the diagnosis of MD until at least all genes responsible for PMD are found and are highly effective in facilitating the diagnosis process.
- Related:
- PHACTboost: A Phylogeny-aware Boosting Algorithm to Compute the Pathogenicity of Missense Mutations
- Cross-species investigation into the requirement of XPA for nucleotide excision repair
- Evolutionary history of Calcium-sensing receptors sheds light into hyper/hypocalcemia-causing mutations
- Sibling rivalry among the ZBTB transcription factor family: homodimers versus heterodimers
- PHACT: Phylogeny-Aware Computing of Tolerance for Missense Mutations
- Common and selective signal transduction mechanisms of GPCRs
- Evolutionary association of receptor-wide amino acids with G protein-coupling selectivity in aminergic GPCRs
- Phylostat: a web-based tool to analyze paralogous clade divergence in phylogenetic trees
- The mutation profile of SARS-CoV-2 is primarily shaped by the host antiviral defense
- Phylogenetic analysis of SARS-CoV-2 genomes in Turkey
- Class III histidine kinases: a recently accessorized kinase domain in putative modulators of type IV pili based motility.
- Cache domains are dominant extracellular sensors for signal transduction in prokaryotes.
- Establishing the precise evolutionary history of a gene improves predicting disease-causing missense mutations.